American Century Companies’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding FPRX
BB
EAM
American Century Companies's FPRX Position: Q1 2017 in Review
American Century Companies sold out of Five Prime Therapeutics, Inc. (FPRX) in Q1 2017, closing a stake of 9,197 shares — an estimated $461K sold.
American Century Companies first reported a position in FPRX in Q2 2015 and held it in 2 quarters. The position peaked at $461K in Q4 2016. 157 funds tracked by Wall St. Rank hold FPRX as of Q1 2017.
- American Century Companies reported no remaining Five Prime Therapeutics, Inc. position as of Q1 2017 after selling out during the quarter.
- American Century Companies sold 9,197 Five Prime Therapeutics, Inc. shares in Q1 2017, an estimated $461K.
- American Century Companies first reported a position in Five Prime Therapeutics, Inc. in Q2 2015 and held it in 2 quarters.
- American Century Companies's Five Prime Therapeutics, Inc. position peaked at $461K in Q4 2016.
- 157 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2017.
Based on American Century Companies's 13F filing for Q1 2017, filed 2 May 2017.